Rojas-Flores Segundo, Cabanillas-Chirinos Luis, Nélida Milly Otiniano et al.

World Congress on Civil, Structural, and Environmental Engineering • 2025

- Agricultural waste has increased rapidly in recent years due to increased food production, which has risen due to the increase in the world population. On the other hand, the high cost of energy consumption and scarcity of this sound in remote communities has caused the scientific community to look for new ways to sustain electricity. For this reason, the main objective of this research is to observe the potential of artichoke waste as fuel in single-chamber microbial fuel cells using carbon and zinc electrodes. An average maximum power density of 220.271 ± 11.174 mW/cm 2 was achieved in an average current density of 5.841 ± 0.285 A/cm 2 on the tenth day, with an average maximum voltage of 0.795 ± 0.025 V and an average maximum electric current of 1.980 ± 0.0.072 mA. These electric flies were obtained on the tenth day, where the microbial fuel cells operated at a pH of 4.351 ± 0.161 with an electrical conductivity of 127.844 ± 8.512 mS/cm and an electrical resistance of 40.314 ± 6.813 Ω. The single-chamber microbial fuel cells with artichoke waste were connected in series, producing a 2.35 V voltage necessary to light an LED light.

W. Rojas-Villacorta, S. Rojas-Flores, Santiago M. Benites et al.

Sustainability • 2023

Agricultural waste negatively impacts the environment and generates economic difficulties for agro-industrial companies and farmers. As a result, it is necessary for an eco-friendly and sustainable alternative to managing this type of waste. Therefore, the research aimed to investigate lettuce waste as an alternative substrate to generate bioelectricity in single-chamber microbial fuel cells (scMFCs). It was possible to report voltage and electric current peaks of 0.959 ± 0.026 V and 5.697 ± 0.065 mA on the fourteenth day, values that were attained with an optimum pH of 7.867 ± 0.147 and with an electrical conductivity of 118.964 ± 8.888 mS/cm. Moreover, as time passed the values began to decline slowly. The calculated value of maximum power density was 378.145 ± 5.417 mW/cm2 whose current density was 5.965 A/cm2, while the internal resistance reported using Ohm’s Law was 87.594 ± 6.226 Ω. Finally, it was possible to identify the Stenotrophomonas maltophilia bacterium (99.59%) on a molecular scale, as one of the microorganisms present in the anodic biofilm. The three microbial fuel cells were connected in series and demonstrated that they were capable of lighting an LED bulb, with a voltage of 2.18 V.

M. Zieliński, Łukasz Barczak, Paulina Rusanowska et al.

Energies • 2024

The development and implementation of innovative production technologies have a direct influence on the creation of new sources of pollution and types of waste. An example of this is the wastewater from soil-less agriculture and the effluent from microbial fuel cells. An important topic is the development and application of methods for their neutralisation that take into account the assumptions of global environmental policy. The aim of the present study was to determine the possibilities of utilising this type of pollution in the process of autotrophic cultivation of the biohydrogen-producing microalgae Tetraselmis subcordiformis. The highest biomass concentration of 3030 ± 183 mgVS/L and 67.9 ± 3.5 mg chl-a/L was observed when the culture medium was wastewater from soil-less agriculture. The growth rate in the logarithmic growth phase was 270 ± 16 mgVS/L-day and 5.95 ± 0.24 mg chl-a/L-day. In the same scenario, the highest total H2 production of 161 ± 8 mL was also achieved, with an observed H2 production rate of 4.67 ± 0.23 mL/h. Significantly lower effects in terms of biomass production of T. subcordiformis and H2 yield were observed when fermented dairy wastewater from the anode chamber of the microbial fuel cell was added to the culture medium.

Yushi Tian, Xiaoxue Mei, Qing Liang et al.

RSC Advances • 0

<p>The syntrophic interactions between polysaccharide-degrading bacteria and exoelectrogens drove simultaneous alternative energy production and degradation of potato pulp waste in microbial fuel cells.</p>

Harshika Gupta, Smita Singh, Dr. Maj. Neerja Masih

Futuristic Trends in Biotechnology Volume 3 Book 21 • 2024

<jats:p>The demand for power is quite significant on a global scale. Microbial Fuel Cell (MFC) Technology may be used to reduce reliance on fossil fuels and to provide alternative sustainable energy sources. MFC Technology uses microorganisms to produce power using the organic matter found in the environment. MFC is a biofuel cell, that generates electricity by converting organic material into electricity. Due to its ability to use wastewater as a substrate and to not require a metal catalyst, it can be taken into consideration as a more sustainable alternative for traditional fuel cells. Waste material are first transformed to chemical energy and then, after being treated to the desired level to electrical energy. An anode, cathode and a separation membrane are the basic components of MFC. MFC technology has the potential to become a more environment friendly fuel cell alternative. Despite being viewed as a promising technology, MFC is not yet commercially viable for usage on a large scale due to its poor current generation per unit cost and high internal resistance. More study should be conducted on the creation of more efficient electrode materials and the development of resilient microorganisms as biocatalysts in order to boost the viability of MFC technology.</jats:p>

Soumya Pandit, Nishit Savla, Jayesh M. Sonawane et al.

Fermentation • 0

<jats:p>In recent years, there has been a significant accumulation of waste in the environment, and it is expected that this accumulation may increase in the years to come. Waste disposal has massive effects on the environment and can cause serious environmental problems. Thus, the development of a waste treatment system is of major importance. Agro-industrial wastewater and waste residues are mainly rich in organic substances, lignocellulose, hemicellulose, lignin, and they have a relatively high amount of energy. As a result, an effective agro-waste treatment system has several benefits, including energy recovery and waste stabilization. To reduce the impact of the consumption of fossil energy sources on our planet, the exploitation of renewable sources has been relaunched. All over the world, efforts have been made to recover energy from agricultural waste, considering global energy security as the final goal. To attain this objective, several technologies and recovery methods have been developed in recent years. The microbial fuel cell (MFC) is one of them. This review describes the power generation using various types of agro-industrial wastewaters and agricultural residues utilizing MFC. It also highlights the techno-economics and lifecycle assessment of MFC, its commercialization, along with challenges.</jats:p>

Vincenzo Patamia, Chiara Zagni, Roberto Fiorenza et al.

Nanomaterials • 2023

Bacterial involvement in cancer’s development, along with their impact on therapeutic interventions, has been increasingly recognized. This has prompted the development of novel strategies to disrupt essential biological processes in microbial cells. Among these approaches, metal-chelating agents have gained attention for their ability to hinder microbial metal metabolism and impede critical reactions. Nanotechnology has also contributed to the antibacterial field by offering various nanomaterials, including antimicrobial nanoparticles with potential therapeutic and drug-delivery applications. Halloysite nanotubes (HNTs) are naturally occurring tubular clay nanomaterials composed of aluminosilicate kaolin sheets rolled multiple times. The aluminum and siloxane groups on the surface of HNTs enable hydrogen bonding with biomaterials, making them versatile in various domains, such as environmental sciences, wastewater treatment, nanoelectronics, catalytic studies, and cosmetics. This study aimed to create an antibacterial material by combining the unique properties of halloysite nanotubes with the iron-chelating capability of kojic acid. A nucleophilic substitution reaction involving the hydroxyl groups on the nanotubes’ surface was employed to functionalize the material using kojic acid. The resulting material was characterized using infrared spectroscopy (IR), thermogravimetric analysis (TGA), energy-dispersive X-ray spectroscopy (EDX), and scanning electron microscopy (SEM), and its iron-chelating ability was assessed. Furthermore, the potential for drug loading—specifically, with resveratrol and curcumin—was evaluated through ultraviolet (UV) analysis. The antibacterial assay was evaluated following CLSI guidelines. The results suggested that the HNTs–kojic acid formulation had great antibacterial activity against all tested pathogens. The outcome of this work yielded a novel bio-based material with dual functionality as a drug carrier and an antimicrobial agent. This innovative approach holds promise for addressing challenges related to bacterial infections, antibiotic resistance, and the development of advanced therapeutic interventions.

Mehrnaz Fayazi, Mitra Rostami, Masoud Amiri Moghaddam et al.

Journal of Drug Targeting • 2024

Abstract Periodontitis (PD) is a chronic gum illness that may be hard to cure for a number of reasons, including the fact that no one knows what causes it, the side effects of anti-microbial treatment, and how various kinds of bacteria interact with one another. As a result, novel therapeutic approaches for PD treatment must be developed. Additionally, supplementary antibacterial regimens, including local and systemic medication administration of chemical agents, are necessary for deep pockets to assist with mechanical debridement of tooth surfaces. As our knowledge of periodontal disease and drug delivery systems (DDSs) grows, new targeted delivery systems like extracellular vesicles, lipid-based nanoparticles (NPs), metallic NPs, and polymer NPs have been developed. These systems aim to improve the targeting and precision of PD treatments while reducing the systemic side effects of antibiotics. Nanozymes, photodermal therapy, antibacterial metallic NPs, and traditional PD therapies have all been reviewed in this research. Medicinal herbs, antibiotics, photothermal therapy, nanozymes, antibacterial metallic NPs, and conventional therapies for PD have all been examined in this research. After that, we reviewed the key features of many innovative DDSs and how they worked for PD therapy. Finally, we have discussed the advantages and disadvantages of these DDSs. Graphical Abstract

Leyi Xiao, Mengge Feng, Chen Chen et al.

Advanced Materials • 2023

The oral cavity comprises an environment full of microorganisms. Dysregulation of this microbial-cellular microenvironment will lead to a series of oral diseases, such as implant-associated infection caused by Staphylococcus aureus (S. aureus) biofilms and periodontitis initiated by Streptococcus oralis (S. oralis). In this study, a liposome-encapsulated indocyanine green (ICG) and rapamycin drug-delivery nanoparticle (ICG-rapamycin) is designed to treat and prevent two typical biofilm-induced oral diseases by regulating the microbial-cellular microenvironment. ICG-rapamycin elevates the reactive oxygen species (ROS) and temperature levels to facilitate photodynamic and photothermal mechanisms under near-infrared (NIR) laser irradiation for anti-bacteria. In addition, it prevents biofilm formation by promoting bacterial motility with increasing the ATP levels. The nanoparticles modulate the microbial-cellular interaction to reduce cellular inflammation and enhance bacterial clearance, which includes promoting the M2 polarization of macrophages, upregulating the anti-inflammatory factor TGF-β, and enhancing the bacterial phagocytosis of macrophages. Based on these findings, ICG-rapamycin is applied to implant-infected and periodontitis animal models to confirm the effects in vivo. This study demonstrates that ICG-rapamycin can treat and prevent biofilm-induced oral diseases by regulating the microbial-cellular microenvironment, thus providing a promising strategy for future clinical applications.

Jian Gao, Jiannan Li, Zengyou Luo et al.

Drug Design, Development and Therapy • 2024

Abstract Inflammatory bowel disease (IBD) is a chronic, non-specific inflammatory condition characterized by recurring inflammation of the intestinal mucosa. However, the existing IBD treatments are ineffective and have serious side effects. The etiology of IBD is multifactorial and encompasses immune, genetic, environmental, dietary, and microbial factors. The nanoparticles (NPs) developed based on specific targeting methodologies exhibit great potential as nanotechnology advances. Nanoparticles are defined as particles between 1 and 100 nm in size. Depending on their size and surface functionality, NPs exhibit different properties. A variety of nanoparticle types have been employed as drug carriers for the treatment of inflammatory bowel disease (IBD), with encouraging outcomes observed in experimental models. They increase the bioavailability of drugs and enable targeted drug delivery, promoting localized treatment and thus enhancing efficacy. Nevertheless, numerous challenges persist in the translation from nanomedicine to clinical application, including enhanced formulations and preparation techniques, enhanced drug safety profiles, and so forth. In the future, it will be necessary for scientists and clinicians to collaborate in order to study disease mechanisms, develop new drug delivery strategies, and screen new nanomedicines. Nevertheless, numerous challenges persist in the translation from nanomedicine to clinical application, including enhanced formulations and preparation techniques, enhanced drug safety profiles, and so forth. In the future, it will be necessary for scientists and clinicians to collaborate in order to study disease mechanisms, develop new drug delivery strategies, and screen new nanomedicines.

Rokeya Sultana, Sourav Mohanto, Adrija Bhunia et al.

Current Drug Delivery • 2024

The utilization of novel drug delivery systems loaded with essential oils has gained significant attention as a promising approach for biomedical applications in recent years. Plants possess essential oils that exhibit various medicinal properties, i.e., anti-oxidant, anti-microbial, anti- inflammatory, anti-cancer, immunomodulatory, etc., due to the presence of various phytoconstituents, including terpenes, phenols, aldehydes, ketones, alcohols, and esters. An understanding of conventional and advanced extraction techniques of Essential Oils (EOs) from several plant sources is further required before considering or loading EOs into drug delivery systems. Therefore, this article summarizes the various extraction techniques of EOs and their existing limitations. The in-built biological applications of EOs are of prerequisite importance for treating several diseases. Thus, the mechanisms of action of EOs for anti-inflammatory, anti-oxidant, anti-bacterial activities, etc., have been further explored in this article. The encapsulation of essential oils in micro or nanometric systems is an intriguing technique to render adequate stability to the thermosensitive compounds and shield them against environmental factors that might cause chemical degradation. Thus, the article further summarizes the advanced drug delivery approaches loaded with EOs and current challenges in the future outlook of EOs for biomedical applications.

S. Gulati, Nabeela Ansari, Yamini Moriya et al.

Journal of Materials Chemistry B • 2024

Nanobiopolymers have emerged as a transformative frontier in cancer treatment, leveraging nanotechnology to transform drug delivery. This review provides a comprehensive exploration of the multifaceted landscape of nano-based biopolymers, emphasizing their diverse sources, synthesis methods, and classifications. Natural, synthetic, and microbial nanobiopolymers are scrutinized, along with elucidation of their underlying mechanisms and impact on cancer drug delivery; the latest findings on their deployment as targeted drug delivery agents for cancer treatment are discussed. A detailed analysis of nanobiopolymer sources, including polysaccharides, peptides, and nucleic acids, highlights critical attributes like biodegradability, renewability, and sustainability essential for therapeutic applications. The classification of nanobiopolymers based on their origin and differentiation among natural, synthetic, and microbial sources are thoroughly examined for inherent advantages, challenges, and suitability for cancer therapeutics. The importance of targeted drug release at tumour sites, crucial for minimizing adverse effects on normal tissues, is discussed, encompassing various mechanisms. The role of polymer membrane coatings as a pivotal barrier for facilitating controlled drug release through diffusion is elucidated, providing further insight into efficient methods for cancer treatment and thus consolidating the current knowledge base for researchers and practitioners in the field of nanobiopolymers and cancer therapeutics.

Mehdi Yoosefian, Hanieh Sabaghian

Journal of Drug Targeting • 2024

Abstract Nanoparticles (NPs) have played a pivotal role in various biomedical applications, spanning from sensing to drug delivery, imaging and anti-viral therapy. The therapeutic utilisation of NPs in clinical trials was established in the early 1990s. Silver nanoparticles (AgNPs) possess anti-microbial, anti-cancer and anti-viral properties, which make them a possible anti-viral drug to combat the COVID-19 virus. Free radicals and reactive oxygen species are produced by AgNPs, which causes apoptosis induction and prevents viral contamination. The shape and size of AgNPs can influence their interactions and biological activities. Therefore, it is recommended that silver nanoparticles (AgNPs) be used as a valuable tool in the management of COVID-19 pandemic. These nanoparticles possess strong anti-microbial properties, allowing them to penetrate and destroy microbial cells. Additionally, the toxicity level of nanoparticles depends on the administered dose, and surface modifications are necessary to reduce toxicity, preventing direct interaction between metal surfaces and cells. By utilising silver nanoparticles, drugs can be targeted to specific areas in the body. For example, in the case of COVID-19, anti-viral drugs can be stimulated as nanoparticles in the lungs to accelerate disease recovery. Nanoparticle-based systems have the capability to transport drugs and treat specific body parts. This review offers an examination of silver nanoparticle-based drug delivery systems for combatting COVID-19, with the objective of boosting the bioavailability of existing medications, decreasing their toxicity and raising their efficiency.

Miguel Jimenez, R. Langer, G. Traverso

Journal of Experimental Medicine • 2019

With >40 clinical trials underway, we are nearing the first FDA-approved live microbial therapeutic. Here, Giovanni Traverso, MIT and Harvard Medical School Assistant Professor, and colleagues Miguel Jimenez and Institute Professor Robert Langer from MIT discuss the significant challenges of administering live microorganisms to patients and the opportunities for drug delivery of these new complex therapeutics.

Matheus Aparecido dos Santos Ramos, P. D. da Silva, L. Spósito et al.

International Journal of Nanomedicine • 2018

Since the dawn of civilization, it has been understood that pathogenic microorganisms cause infectious conditions in humans, which at times, may prove fatal. Among the different virulent properties of microorganisms is their ability to form biofilms, which has been directly related to the development of chronic infections with increased disease severity. A problem in the elimination of such complex structures (biofilms) is resistance to the drugs that are currently used in clinical practice, and therefore, it becomes imperative to search for new compounds that have anti-biofilm activity. In this context, nanotechnology provides secure platforms for targeted delivery of drugs to treat numerous microbial infections that are caused by biofilms. Among the many applications of such nanotechnology-based drug delivery systems is their ability to enhance the bioactive potential of therapeutic agents. The present study reports the use of important nanoparticles, such as liposomes, microemulsions, cyclodextrins, solid lipid nanoparticles, polymeric nanoparticles, and metallic nanoparticles, in controlling microbial biofilms by targeted drug delivery. Such utilization of these nanosystems has led to a better understanding of their applications and their role in combating biofilms.

Manisha Pandey, H. Choudhury, A. Abdul-Aziz et al.

Polymers • 2020

An optimal host–microbiota interaction in the human vagina governs the reproductive health status of a woman. The marked depletion in the beneficial Lactobacillus sp. increases the risk of infection with sexually transmitted pathogens, resulting in gynaecological issues. Vaginal infections that are becoming increasingly prevalent, especially among women of reproductive age, require an effective concentration of antimicrobial drugs at the infectious sites for complete disease eradication. Thus, topical treatment is recommended as it allows direct therapeutic action, reduced drug doses and side effects, and self-insertion. However, the alterations in the physiological conditions of the vagina affect the effectiveness of vaginal drug delivery considerably. Conventional vaginal dosage forms are often linked to low retention time in the vagina and discomfort which significantly reduces patient compliance. The lack of optimal prevention and treatment approaches have contributed to the unacceptably high rate of recurrence for vaginal diseases. To combat these limitations, several novel approaches including nano-systems, mucoadhesive polymeric systems, and stimuli-responsive systems have been developed in recent years. This review discusses and summarises the recent research progress of these novel approaches for vaginal drug delivery against various vaginal diseases. An overview of the concept and challenges of vaginal infections, anatomy and physiology of the vagina, and barriers to vaginal drug delivery are also addressed.

A. Zaki, El-Sayed R. El-Sayed, M. Abd Elkodous et al.

Applied Microbiology and Biotechnology • 2020

Abstract Neurodegenerative disorders especially Alzheimer’s disease (AD) are significantly threatening the public health. Acetylcholinesterase (AChE) inhibitors are compounds of great interest which can be used as effective agents for the symptomatic treatment of AD. Although plants are considered the largest source for these types of inhibitors, the microbial production of AChE inhibitors represents an efficient, easily manipulated, eco-friendly, cost-effective, and alternative approach. This review highlights the recent advances on the microbial production of AChE inhibitors and summarizes all the previously reported successful studies on isolation, screening, extraction, and detecting methodologies of AChE inhibitors from the microbial fermentation, from the earliest trials to the most promising anti-AD drug, huperzine A (HupA). In addition, improvement strategies for maximizing the industrial production of AChE inhibitors by microbes will be discussed. Finally, the promising applications of nano-material-based drug delivery systems for natural AChE inhibitor (HupA) will also be summarized. Key Points • AChE inhibitors are potential therapies for Alzheimer’s disease. • Microorganisms as alternate sources for prospective production of such inhibitors. • Research advances on extraction, detection, and strategies for production improvement. • Nanotechnology-based approaches for an effective drug delivery for Alzheimer’s disease .

M. Ohadi, A. Shahravan, Negar Dehghannoudeh et al.

Drug Design, Development and Therapy • 2020

Background Microemulsions drug delivery systems (MDDS) have been known to increase the bioavailability of hydrophobic drugs. The main challenge of the MDDS is the development of an effective and safe system for drug carriage and delivery. Biosurfactants are preferred surface-active molecules because of their lower toxicity and safe characteristics when compared to synthetic surfactants. Glycolipid and lipopeptide are the most common biosurfactants that were tested for MDDS. The main goal of the present systematic review was to estimate the available evidence on the role of biosurfactant in the development of MDDS. Search Strategy Literature searches involved the main scientific databases and were focused on the period from 2005 until 2017. The Search filter composed of two items: “Biosurfactant” and/or “Microemulsion.” Inclusion Criteria Twenty-four studies evaluating the use of biosurfactant in MDDS were eligible for inclusion. Among these 14 were related to the use of glycolipid biosurfactants in the MDDS formulations, while four reported using lipopeptide biosurfactants and six other related review articles. Results According to the output study parameters, biosurfactants acted as active stabilizers, hydrophilic or hydrophobic linkers and safety carriers in MDDS, and among them glycolipid biosurfactants had the most application in MDDS formulations. Conclusion Synthetic surfactants could be replaced by biosurfactants as an effective bio-source for MDDS due to their excellent self-assembling and emulsifying activity properties.

Ankur Sharma, Dhruv Kumar, Kajal Dahiya et al.

Nanomedicine • 2021

The increasing burden of respiratory diseases caused by microbial infections poses an immense threat to global health. This review focuses on the various types of biofilms that affect the respiratory system and cause pulmonary infections, specifically bacterial biofilms. The article also sheds light on the current strategies employed for the treatment of such pulmonary infection-causing biofilms. The potential of nanocarriers as an effective treatment modality for pulmonary infections is discussed, along with the challenges faced during treatment and the measures that may be implemented to overcome these. Understanding the primary approaches of treatment against biofilm infection and applications of drug-delivery systems that employ nanoparticle-based approaches in the disruption of biofilms are of utmost interest which may guide scientists to explore the vistas of biofilm research while determining suitable treatment modalities for pulmonary respiratory infections.

K. Sachin, S. K. Karn

Frontiers in Chemistry • 2021

The emergence of nanosystems for different biomedical and drug delivery applications has drawn the attention of researchers worldwide. The likeness of microorganisms including bacteria, yeast, algae, fungi, and even viruses toward metals is well-known. Higher tolerance to toxic metals has opened up new avenues of designing microbial fabricated nanomaterials. Their synthesis, characterization and applications in bioremediation, biomineralization, and as a chelating agent has been well-documented and reviewed. Further, these materials, due to their ability to get functionalized, can also be used as theranostics i.e., both therapeutic as well as diagnostic agents in a single unit. Current article attempts to focus particularly on the application of such microbially derived nanoformulations as a drug delivery and targeting agent. Besides metal-based nanoparticles, there is enough evidence wherein nanoparticles have been formulated using only the organic component of microorganisms. Enzymes, peptides, polysaccharides, polyhydroxyalkanoate (PHA), poly-(amino acids) are amongst the most used biomolecules for guiding crystal growth and as a capping/reducing agent in the fabrication of nanoparticles. This has promulgated the idea of complete green chemistry biosynthesis of nano-organics that are most sought after in terms of their biocompatibility and bioavailability.

A. Shariati, Z. Chegini, E. Ghaznavi-Rad et al.

Frontiers in Cellular and Infection Microbiology • 2022

The biofilm community of microorganisms has been identified as the dominant mode of microbial growth in nature and a common characteristic of different microorganisms such as Pseudomonas aeruginosa, Staphylococcus aureus, and Staphylococcus epidermidis. The biofilm structure helps in the protection from environmental threats including host immune system and antimicrobial agents. Thus, the biofilm community has led to a higher prevalence of multidrug-resistant (MDR) strains in recent years. In this regard, the use of a new class of antibiotics, natural compounds, and anti-biofilm enzymes has been considered for the destruction of the microbial biofilm. However, different drawbacks such as low penetration, high susceptibility to degradation, instability, and poor solubility in aqueous solutions limit the use of anti-biofilm agents (ABAs) in a clinical setting. As such, recent studies have been using poly lactic-co-glycolic acid (PLGA)-based nanoplatforms (PLGA NPFs) for delivery of ABAs that have reported promising results. These particles, due to proper drug loading and release kinetics, could suppress microbial attachment, colonization, and biofilm formation for a long time. Additionally, PLGA NPFs, because of the high drug-loading efficiencies, hydrophilic surface, negative charge, and electrostatic interaction, lead to effective penetration of antibiotics to the deeper layer of the biofilm, thereby eliminating the microbial biofilm. Thus, PLGA NPFs could be considered as a potential candidate for coating catheters and other medical material surfaces for inhibition and destruction of the microbial biofilm. However, the exact interaction of PLGA NPFs and the microbial biofilm should be evaluated in animal studies. Additionally, a future goal will be to develop PLGA formulations as systems that can be used for the treatment of the MDR microbial biofilm, since the exact interactions of PLGA NPFs and these biofilm structures are not elucidated. In the present review article, we have discussed various aspects of PLGA usage for inhibition and destruction of the microbial biofilm along with different methods and procedures that have been used for improving PLGA NPF efficacy against the microbial biofilm.

P. Gotovtsev

Biomimetics • 2023

The presented review focused on the microbial cell based system. This approach is based on the application of microorganisms as the main part of a robot that is responsible for the motility, cargo shipping, and in some cases, the production of useful chemicals. Living cells in such microrobots have both advantages and disadvantages. Regarding the advantages, it is necessary to mention the motility of cells, which can be natural chemotaxis or phototaxis, depending on the organism. There are approaches to make cells magnetotactic by adding nanoparticles to their surface. Today, the results of the development of such microrobots have been widely discussed. It has been shown that there is a possibility of combining different types of taxis to enhance the control level of the microrobots based on the microorganisms’ cells and the efficiency of the solving task. Another advantage is the possibility of applying the whole potential of synthetic biology to make the behavior of the cells more controllable and complex. Biosynthesis of the cargo, advanced sensing, on/off switches, and other promising approaches are discussed within the context of the application for the microrobots. Thus, a synthetic biology application offers significant perspectives on microbial cell based microrobot development. Disadvantages that follow from the nature of microbial cells such as the number of external factors influence the cells, potential immune reaction, etc. They provide several limitations in the application, but do not decrease the bright perspectives of microrobots based on the cells of the microorganisms.

M. Puccetti, M. Pariano, P. Wojtyło et al.

Pharmaceutics • 2023

Developing therapeutics for inflammatory diseases is challenging due to physiological mucosal barriers, systemic side effects, and the local microbiota. In the search for novel methods to overcome some of these problems, drug delivery systems that improve tissue-targeted drug delivery and modulate the microbiota are highly desirable. Microbial metabolites are known to regulate immune responses, an observation that has resulted in important conceptual advances in areas such as metabolite pharmacology and metabolite therapeutics. Indeed, the doctrine of “one molecule, one target, one disease” that has dominated the pharmaceutical industry in the 20th century is being replaced by developing therapeutics which simultaneously manipulate multiple targets through novel formulation approaches, including the multitarget-directed ligands. Thus, metabolites may not only represent biomarkers for disease development, but also, being causally linked to human diseases, an unexploited source of therapeutics. We have shown the successful exploitation of this approach: by deciphering how signaling molecules, such as the microbial metabolite, indole-3-aldehyde, and the repurposed drug anakinra, interact with the aryl hydrocarbon receptor may pave the way for novel therapeutics in inflammatory human diseases, for the realization of which drug delivery platforms are instrumental.

Heli Siti Halimatul Munawaroh, B. Anwar, G. Yuliani et al.

Bioengineered • 2023

ABSTRACT Phycocyanin, produced by Spirulina platensis, has been reported as an anti-inflammatory, anti-hyperalgesia, antioxidant, anti-tumor, and anti-cancer agent. However, the ingestion of phycocyanin in the body is often hindered by its instability against gastric pH conditions. The nano-drug delivery system has developed as a promising platform for efficient drug delivery and improvement as well as drug efficacy. Bacterial cellulose nanocrystal (BCNC) has it superiority as DDS due to its inherent properties such as nanoscale dimension, large surface area, - biocompatibility, and non-toxic. To improve its mechanical properties, BCNC was crosslinked with glutaraldehyde and was analyzed as a potential candidate for DDS. The Fourier transform infrared analysis of the BCNC suggested that hydrolysis did not alter the chemical composition. The index of crystallinity of the BCNC was 18.31% higher than that of the original BC, suggesting that crystalline BC has been successfully isolated. The BCNC particle also showed a needle-like morphology which is 25 ± 10 nm in diameter and a mean length of 626 ± 172 nm. Crosslinked BCNC also had larger pores than the original BCNC along with higher thermal stability. Optimum phycocyanin adsorption on crosslinked BCNC reached 65.3% in 3 h. The release study shows that the crosslinked BCNC can protect the phycocyanin retardation by gastric fluid until phycocyanin reaches the targeted sites. This study provides an alternative potential DDS derived from natural bioresources with less expenses and better properties to promote the application of BCNC as functional nanomaterials in biomedical science.

Tongjiang He, Zhendong Zhao, Zhentao Luo et al.

Acta Materia Medica • 2023

Microorganisms are mostly distributed on the surface of our skin and intestines and have crucial roles in physiologic and metabolic processes, such as digestion and immunity, which are closely related to diseases. Recently, microorganisms have received great attention and have been applied in various aspects of biomedicine, especially in the field of drug delivery. However, the application of bacteria has been largely limited due to the intrinsic nature of bacteria, including rapid proliferation, toxicity, and immunogenicity. Therefore, microbial decoration is an attention-grabbing approach to drug delivery by altering the properties and functions of microbial surfaces. Microbial decoration methods are diverse and include biotin-affinity and gene decoration technologies. These approaches can improve the specific delivery of drugs, enhance the stability and controlled release of drug delivery vehicles, and are useful in cancer therapy, gene therapy, and vaccine delivery. Microbial decoration has broad application prospects by helping develop smarter and more precise drug delivery systems and providing more effective and safer therapeutic options for patients. In this review we summarize the research progress in different microbial surface modification methods and the applications in drug delivery, as well as the outlook for future opportunities in this field.

Aigerim Yermagambetova, S. Tazhibayeva, P. Takhistov et al.

Polymers • 2024

This review examines microbial polysaccharides’ properties relevant to their use in packaging and pharmaceutical applications. Microbial polysaccharides are produced by enzymes found in the cell walls of microbes. Xanthan gum, curdlan gum, pullulan, and bacterial cellulose are high-molecular-weight substances consisting of sugar residues linked by glycoside bonds. These polysaccharides have linear or highly branched molecular structures. Packaging based on microbial polysaccharides is readily biodegradable and can be considered as a renewable energy source with the potential to reduce environmental impact. In addition, microbial polysaccharides have antioxidant and prebiotic properties. The physico-chemical properties of microbial polysaccharide-based films, including tensile strength and elongation at break, are also evaluated. These materials’ potential as multifunctional packaging solutions in the food industry is demonstrated. In addition, their possible use in medicine as a drug delivery system is also considered.

Chenyu Zong, Fei Wang, Wenguo Cui

Research • 2025

<jats:p> <jats:italic toggle="yes">In situ</jats:italic> microbial aerodynamic microneedles (MM-MNs) represent an autonomous transdermal drug delivery platform that utilizes the gas generated by microbial metabolism (e.g., H <jats:sub>2</jats:sub> , NO, and H <jats:sub>2</jats:sub> S) to propel drugs into deep tissues, surpassing the penetration limits of traditional microneedles reliant on external stimuli (heat/light/mechanical force). By leveraging controlled microbial metabolism, MM-MNs enable energy-independent, spatiotemporally precise delivery with enhanced targeting and bioavailability. Gas-driven propulsion combines with bioactive gas functions (e.g., NO-induced vasodilation and H <jats:sub>2</jats:sub> S-mediated anti-inflammation) to modulate disease microenvironments. The system’s biocompatibility (probiotic strains and <jats:italic toggle="yes">Lactobacillus</jats:italic> ) and scalability (cost-effective patch design) further support its potential for localized therapies (skin diseases and tumors) with minimized systemic exposure. This innovation bridges microbial biotechnology and precision medicine, offering a paradigm shift in transdermal delivery. </jats:p>

Yasutaka Shimizu, J. Fastier-Wooller, Yoshihiro Muneta et al.

2024 IEEE SENSORS • 2024

Long term diagnostics and health monitoring of inaccessible sensors require strenuous power management or alternate power generation methods. Intraruminal devices can be powered with green energy using a microbial fuel cell (MFC). However, issues concerning poor steady-state power generation in anaerobic environments must be addressed. In this study, we propose a new type of structure of MFC for power generation in the rumen of cattle. Steady-state performance is evaluated with electrodes of 3 different materials. Using our proposed structure, the MFC's voltage drop in anaerobic environments is minimized, and each material electrode displayed a maximum power generation characteristic as follows: 0.4 µW/cm2 for gold, 0.15 µW/cm2 for platinum, and 0.002 µW/cm2 for carbon.

Lin Liu, Seokheun Choi

SLAS Technology • 2019

A merged system incorporating paperfluidics and papertronics has recently emerged as a simple, single-use, low-cost paradigm for disposable point-of-care (POC) diagnostic applications. Stand-alone and self-sustained paper-based systems are essential to providing effective and lifesaving treatments in resource-constrained environments. Therefore, a realistic and accessible power source is required for actual paper-based POC systems as their diagnostic performance and portability rely significantly on power availability. Among many paper-based batteries and energy storage devices, paper-based microbial fuel cells have attracted much attention because bacteria can harvest electricity from any type of organic matter that is readily available in those challenging regions. However, the promise of this technology has not been translated into practical power applications because of its short power duration, which is not enough to fully operate those systems for a relatively long period. In this work, we for the first time demonstrate a simple and long-lasting paper-based biological solar cell that uses photosynthetic bacteria as biocatalysts. The bacterial photosynthesis and respiration continuously and self-sustainably generate power by converting light energy into electricity. With a highly porous and conductive anode and an innovative solid-state cathode, the biological solar cell built upon the paper substrates generated the maximum current and power density of 65 µA/cm2 and 10.7 µW/cm2, respectively, which are considerably greater than those of conventional micro-sized biological solar cells. Furthermore, photosynthetic bacteria in a 3-D volumetric chamber made of a stack of papers provided stable and long-lasting electricity for more than 5 h, while electrical current from the heterotrophic culture on 2-D paper dramatically decreased within several minutes.

Anwar Elhadad, Yang Gao, Seokheun Choi

Advanced Materials Technologies • 2023

Single‐use electrical systems represent the future of multiple fields such as diagnostic medical technologies, environmental studies, and biofuel manufacturing with significant advantages over conventional unrecyclable bulky systems that are partly disposable at best. Single‐use systems require miniaturized bio‐friendly energy sources that meet the recyclability or reusability requirement of the application without creating toxic waste. Herein, a storable, scalable, and single‐use electronics‐compatible bio‐battery that is designed and fabricated using completely reusable and recyclable components is developed. The battery is a dual‐in‐line package microbial fuel cell (DIP‐MFC) that can be activated on demand via the introduction of moisture through the anodic fluid chamber. The battery incorporates dormant bacteria cells on an abiotic stainless steel mesh that serves as the anode that attracts electrons being transferred from the biocatalyst. The DIP‐MFC uses the infestation of bacterial biofilm on a conductive anode to harness electrons and deliver electricity to selected circuit pins. A single DIP‐MFC continuously operates for 140 min with a maximum open circuit voltage of 0.55 V, which can be stacked and connected to match the power requirements of targeted electronics. The DIP nature of the proposed bio‐battery allows for simple integration of the MFC on conventional electronics boards through conductive pins.

Chloé Grazon, R. Baer, Uroš Kuzmanović et al.

Nature Communications • 2020

Bacteria are an enormous and largely untapped reservoir of biosensing proteins. We describe an approach to identify and isolate bacterial allosteric transcription factors (aTFs) that recognize a target analyte and to develop these TFs into biosensor devices. Our approach utilizes a combination of genomic screens and functional assays to identify and isolate biosensing TFs, and a quantum-dot Förster Resonance Energy Transfer (FRET) strategy for transducing analyte recognition into real-time quantitative measurements. We use this approach to identify a progesterone-sensing bacterial aTF and to develop this TF into an optical sensor for progesterone. The sensor detects progesterone in artificial urine with sufficient sensitivity and specificity for clinical use, while being compatible with an inexpensive and portable electronic reader for point-of-care applications. Our results provide proof-of-concept for a paradigm of microbially-derived biosensors adaptable to inexpensive, real-time sensor devices. Bacteria represent an unexploited reservoir of biosensing proteins. Here the authors use genomic screens and functional assays to isolate a progesterone sensing allosteric transcription factor and use a FRET-based method to develop an optical progesterone sensor.

A. Kharkova, V. A. Arlyapov, Anastasia Medvedeva et al.

Sensors • 2022

Microbial mediator biosensors for surface water toxicity determination make it possible to carry out an early assessment of the environmental object’s quality without time-consuming standard procedures based on standard test-organisms, and provide broad opportunities for receptor element modifying depending on the required operational parameters analyzer. Four microorganisms with broad substrate specificity and nine electron acceptors were used to form a receptor system for toxicity assessment. Ferrocene was the most effective mediator according to its high rate constant of interaction with the microorganisms (0.33 ± 0.01 dm3/(g × s) for yeast Saccharomyces cerevisiae). Biosensors were tested on samples containing four heavy metal ions (Cu2+, Zn2+, Pb2+, Cd2+), two phenols (phenol and p-nitrophenol), and three natural water samples. The «ferrocene- Escherichia coli» and «ferrocene-Paracoccus yeei, E. coli association» systems showed good operational stability with a relative standard deviation of 6.9 and 7.3% (14 measurements) and a reproducibility of 7 and 5.2% using copper (II) ions as a reference toxicant. Biosensor analysis with these systems was shown to highly correlate with the results of the standard method using Chlorella algae as a test object. Developed biosensors allow for a valuation of the polluted natural water’s impact on the ecosystem via an assessment of the influence on bacteria and yeast in the receptor system. The systems could be used in toxicological monitoring of natural waters.

Caitlin Crews-Stowe, Elizabeth Lambert, Lori Berthelot et al.

Antimicrobial Stewardship &amp; Healthcare Epidemiology • 2023

Background: Healthcare floors are a vehicle and/or source for potential pathogens that cause healthcare associated infections, and hospital floors are often heavily contaminated with pathogens such as Clostridioides difficile and methicillin-resistant Staphylococcus aureus. However, definitive research linking reductions in floor burden to reductions in HAIs has not yet been established. We sought to evaluate emerging technology for continuous disinfection and its potential impact on HAIs. This study was designed to explore the potential relationship between the reduction of microbial burden of floors and healthcare associated infections. Methods: A prospective study was conducted in a 22-bed medical-surgical intensive care unit in a 180-bed suburban hospital near New Orleans, Louisiana, from November 2021 to June 2022. Using sterile, premoistened sponges, samples were collected from the floors of 10 areas throughout the unit including 2 nurses’ stations, the physician charting area, and 7 patient rooms. The advanced photocatalytic oxidation (aPCO) equipment was then installed in the HVAC ductwork throughout the ICU and activated. Environmental surface sampling of the same floor surfaces was then repeated every 4 weeks for the first 5 months of the study. HAIs were also tracked throughout the entire study period. The facility’s normal cleaning floor protocols using a neutralizing floor cleaner were unchanged and followed during the study. Changes in surface burden were calculated using a repeated-methods ANOVA with post hoc analyses as appropriate. Rates of healthcare associated infections were compared using χ2 analyses. Results: Overall, there was a 99.6% statistically significant decrease in floor environmental surface burden from the baseline to the final postactivation test (Fig. 1). The average colony forming unit count (CFU) decreased from 318,850 CFU per 100 cm2 to just 2,988 CFU per 100 cm2. The unit also saw a statistically significant decrease in publicly reported healthcare associated infections (HO-MRSA, CLABSI, HO-CDI) during the study period compared to the same period a year prior and in the 6 months immediately prior to the beginning of the study (Fig. 2). Conclusions: Advanced photocatalytic oxidation technology resulted in a reduction of microbial burden on the floors of a high-traffic intensive care unit. Statistically significant decreases in healthcare-associated infections was also seen. This study highlights a novel aPCO technology and its efficacy at reducing microbial burden and healthcare-associated infections despite no change in practice. Disclosures: None

A. Costello, J. Parker, M. Clynes et al.

Metallomics • 2020

The modern world has seen exposure of bacterial communities to toxic metals at selective levels. This manifests itself both intentionally, through medicines and un-intentionally through waste streams. There is growing concern that selective exposure to metals may be linked to microbial resistance to antibiotics. For a microbe to become resistant to a specific metal it must first come in contact with it. The transition metal copper has the ability to enter bacterial cells without need for a copper specific uptake mechanism. Copper is commonly used as an antimicrobial in the healthcare industry, consumer products and as a growth promoter of livestock in the agricultural sector. Here we report a study into the uptake of different organic and inorganic sources of copper. A whole-cell bacterial biosensor was developed to quantify the specific uptake of copper from various sources. Furthermore, a cell-free sensor was utilized to investigate the response to copper sources when uptake is eliminated as a factor. The data within suggest inorganic copper to have greatly reduced uptake compared to organic sources and that there is significant difference between copper oxides, Cu2O and CuO.

R. Funari, A. Shen

ACS Sensors • 2022

Microbial biofilms have caused serious concerns in healthcare, medical, and food industries because of their intrinsic resistance against conventional antibiotics and cleaning procedures and their capability to firmly adhere on surfaces for persistent contamination. These global issues strongly motivate researchers to develop novel methodologies to investigate the kinetics underlying biofilm formation, to understand the response of the biofilm with different chemical and physical treatments, and to identify biofilm-specific drugs with high-throughput screenings. Meanwhile microbial biofilms can also be utilized positively as sensing elements in cell-based sensors due to their strong adhesion on surfaces. In this perspective, we provide an overview on the connections between sensing and microbial biofilms, focusing on tools used to investigate biofilm properties, kinetics, and their response to chemicals or physical agents, and biofilm-based sensors, a type of biosensor using the bacterial biofilm as a biorecognition element to capture the presence of the target of interest by measuring the metabolic activity of the immobilized microbial cells. Finally we discuss possible new research directions for the development of robust and rapid biofilm related sensors with high temporal and spatial resolutions, pertinent to a wide range of applications.

S. Bobade, D. Kalorey, S. Warke

Bioscience Biotechnology Research Communications • 2016

The natural biosensors are chemical sense organs specially designed on the basis of smell and taste likewise. Biosensor is a device that detects, transmits and records information regarding physiological or biochemical changes. Basically it is the probe that integrates a biological component with an electronic transducer thereby converting biochemical signals into electrochemical, optical, acoustic and electronic ones. The function of a biosensor depends on specifi city of biological active material and the analyte to be detected such as chemical compound, antigen, microbes, hormones, nucleic acid or any subjective parameter like smell and taste. The biological sensing elements have been used as enzyme, antibody, DNA ,receptor ,organelles and micro-organism as well as animal and plant tissues. Types of biosensor includes immunosensors, microbial biosensors, whole cell based, electrochemical, optical and acoustic biosensors, which have vast applications in biomedical research, healthcare, pharmaceutical, environmental monitoring, homemade security and battlefi elds. In this review a summary of relevant aspects concerning biosensor integration in effi cient analytical setups and the latest applications of biosensors in diagnostic applications focusing on detection of molecular biomarkers in real samples is included. An overview of the current state and future trends of biosensors in this fi eld is given.

Taeho Yu, Minjee Chae, Ziling Wang et al.

Microbial Biotechnology • 2025

<jats:title>ABSTRACT</jats:title><jats:p>The combination of artificial intelligence (AI) with microbial technology marks the start of a major transformation, improving applications throughout biotechnology, especially in healthcare. With the capability of AI to process vast amounts of biological big data, advanced microbial technology allows for a comprehensive understanding of complex biological systems, advancing disease diagnosis, treatment and the development of microbial therapeutics. This mini review explores the impact of AI‐integrated microbial technologies in healthcare, highlighting advancements in microbial biomarker‐based diagnosis, the development of microbial therapeutics and the microbial production of therapeutic compounds. This exploration promises significant improvements in the design and implementation of health‐related solutions, steering a new era in biotechnological applications.</jats:p>

Tuoyu Zhou, Huawen Han, Pu Liu et al.

Sensors • 0

<jats:p>With the unprecedented deterioration of environmental quality, rapid recognition of toxic compounds is paramount for performing in situ real-time monitoring. Although several analytical techniques based on electrochemistry or biosensors have been developed for the detection of toxic compounds, most of them are time-consuming, inaccurate, or cumbersome for practical applications. More recently, microbial fuel cell (MFC)-based biosensors have drawn increasing interest due to their sustainability and cost-effectiveness, with applications ranging from the monitoring of anaerobic digestion process parameters (VFA) to water quality detection (e.g., COD, BOD). When a MFC runs under correct conditions, the voltage generated is correlated with the amount of a given substrate. Based on this linear relationship, several studies have demonstrated that MFC-based biosensors could detect heavy metals such as copper, chromium, or zinc, as well as organic compounds, including p-nitrophenol (PNP), formaldehyde and levofloxacin. Both bacterial consortia and single strains can be used to develop MFC-based biosensors. Biosensors with single strains show several advantages over systems integrating bacterial consortia, such as selectivity and stability. One of the limitations of such sensors is that the detection range usually exceeds the actual pollution level. Therefore, improving their sensitivity is the most important for widespread application. Nonetheless, MFC-based biosensors represent a promising approach towards single pollutant detection.</jats:p>

Z. N. Temirzhanova

Bulletin of Shakarim University. Technical Sciences • 0

<jats:p>In this review, we discussed the design and manufacture of point-of-care test (POST) devices for the detection of microbial pathogens, including bacteria, viruses, fungi, and parasites. Electrochemical methods and current advances in the field were highlighted in terms of integrated electrochemical platforms, which include mainly microfluidic based approaches and integrated smartphone and Internet of things (IoM) and internet of medical things (IoMT) systems. In addition, the availability of commercial biosensors for the detection of microbial pathogens will be reported. At the end, challenges in point-of-care (POC) biosensor fabrication and expected future advances in biosensor technology were discussed. Integrated biosensor-based platforms with IoM/IoMT typically collect data to track the spread of infectious diseases in the community, which would be useful in terms of better preparedness for current and future pandemics and is expected to prevent social and economic losses.</jats:p><jats:p>In the last decade, the science of biosensors has made tremendous progress in diagnosing diseases. Drug-resistant bacteria are outperforming drug discovery efforts, jeopardizing modern antibiotics and threatening many inevitable medical procedures that are taken for granted. Combating this worldwide threat will require the invention and application of ever-wider diagnostics of infectious diseases.</jats:p>

E. D. Di Domenico, A. Oliva, M. Guembe

Microorganisms • 2022

Biofilm is the trigger for the majority of infections caused by the ability of microorganisms to adhere to tissues and medical devices. Microbial cells embedded in the biofilm matrix are highly tolerant to antimicrobials and escape the host immune system. Thus, the refractory nature of biofilm-related infections (BRIs) still represents a great challenge for physicians and is a serious health threat worldwide. Despite its importance, the microbiological diagnosis of a BRI is still difficult and not routinely assessed in clinical microbiology. Moreover, biofilm bacteria are up to 100–1000 times less susceptible to antibiotics than their planktonic counterpart. Consequently, conventional antibiograms might not be representative of the bacterial drug susceptibility in vivo. The timely recognition of a BRI is a crucial step to directing the most appropriate biofilm-targeted antimicrobial strategy.